Hyperfine, Inc. (HYPR) stock
HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3028% below fair value
$0.55+0.02 (+4.27%)
Close on Nov 20, 2026Market cap $57.96MP/E –Yield –
Hyperfine gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Hyperfine's gross profit for the twelve months ending Jun 30, 2026 was $8.50M, up 71.9% year over year. For fiscal 2025 it was $6.75M, up 14.6% from the year before. The highest annual figure on record is $6.75M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.75M | +14.6% |
| FY2024 | Dec 31, 2024 | $5.89M | +23.8% |
| FY2023 | Dec 31, 2023 | $4.76M | +424.5% |
| FY2022 | Dec 31, 2022 | $907.00K | – |
| FY2021 | Dec 31, 2021 | -$1.17M | – |
| FY2020 | Dec 31, 2020 | -$477.00K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.98M | +49.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.98M | +124.1% |
| Q4 FY2025 | Dec 31, 2025 | $2.69M | +226.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.85M | -3.1% |
| Q2 FY2025 | Jun 30, 2025 | $1.33M | -26.3% |
| Q1 FY2025 | Mar 31, 2025 | $883.00K | -34.8% |
| Q4 FY2024 | Dec 31, 2024 | $826.00K | -20.1% |
| Q3 FY2024 | Sep 30, 2024 | $1.91M | +69.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.80M | +24.9% |
| Q1 FY2024 | Mar 31, 2024 | $1.35M | +17.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.03M | +244.7% |
| Q3 FY2023 | Sep 30, 2023 | $1.12M | +63.4% |
| Q2 FY2023 | Jun 30, 2023 | $1.44M | – |
| Q1 FY2023 | Mar 31, 2023 | $1.16M | +1275.0% |
| Q4 FY2022 | Dec 31, 2022 | $300.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $688.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$165.00K | – |
| Q1 FY2022 | Mar 31, 2022 | $84.00K | – |
| Q4 FY2021 | Dec 31, 2021 | -$453.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$338.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$99.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$277.00K | – |
See a number that looks wrong?